Candida Auris Is Making Headlines—Should You Be Concerned?
Recent reports about Candida auris have raised concern across the United States. News outlets sometimes call it a drug-resistant superbug or link it to a deadly fungus outbreak because it can cause severe illness and resist several antifungal medications.
However, it mainly affects seriously ill patients in hospitals and long-term care facilities. Most healthy people in the community face a low risk.
Primary Care Guidance
Concerned About Symptoms After a Hospital Stay?
If you have unexplained symptoms after a recent hospital stay or want to understand your personal risk, schedule an appointment with Passion Health Advanced Primary Care. A primary care provider can evaluate your symptoms and guide you toward the right level of care.
Quick Health Guide
Key Takeaways
Candida auris is a yeast that can cause severe infections.
It spreads mainly in hospitals and long-term care facilities.
Seriously ill patients and people with invasive medical devices face a higher risk.
Careful screening, cleaning, and hand hygiene can limit transmission.
Healthy people without major risk factors rarely develop an infection.
What Is Candida Auris?
Candida auris, also called C. auris or Candidozyma auris, is a type of yeast. Scientists first identified it in Japan in 2009, while health officials reported the first known U.S. cases several years later.
This fungus acts differently from the Candida species that commonly cause oral thrush or vaginal yeast infections. It can remain on skin and healthcare surfaces for long periods. Additionally, some strains resist several antifungal medications.
This yeast can enter the bloodstream and affect other parts of the body. Treatment may become more complex because many people who develop severe C. auris infections already have serious acute or chronic health conditions.
Colonization means the fungus lives on the skin or body without creating symptoms. However, a colonized person may still spread it within a healthcare facility.
Why Is Candida Auris in the News?
New national reports show that U.S. cases have continued to increase.
According to the Centers for Disease Control and Prevention (CDC), more than 3,000 Candida auris cases have occurred across 23 states so far this year.
The CDC recorded more than 6,000 clinical cases during 2024 and says annual case totals continue to rise, although the rate of growth has slowed since 2022. Some regions have also reported continued transmission within healthcare facilities.
These figures have fueled headlines about a deadly fungus outbreak. Although the wording attracts attention, it requires context. Health officials do not describe C. auris as a widespread community infection.
Instead, outbreaks usually occur in hospitals, nursing homes and long-term acute care facilities.
Moreover, increased screening may identify colonized patients who have no symptoms. Therefore, a higher case count may reflect both continuing transmission and stronger detection efforts. The CDC’s tracking information provides the latest national data.
How Candida Auris Spreads
The fungus usually spreads through direct contact with an infected or colonized person. It can also move through contaminated medical equipment, beds, furniture, and other frequently touched surfaces.
Unlike many other yeasts, C. auris can survive on surfaces for weeks. Consequently, healthcare facilities need cleaning products that work against this specific organism.
Patients may also carry the fungus between hospitals, nursing homes and other facilities. Medical devices such as catheters, breathing tubes, feeding tubes and central lines can increase risk because they provide possible pathways into the body.
However, everyday contact at schools, workplaces or stores presents a much lower risk.
Candida Auris Risk Factors
Most healthy people do not develop a Candida auris infection. Instead, the fungus usually affects people who already have serious medical problems or require intensive healthcare.
Important Candida auris risk factors include:
A weakened immune system
A prolonged or frequent hospital stay
Residence in a nursing home or long-term care facility
A catheter, central line, feeding tube or breathing tube
Recent surgery or complex medical treatment
Diabetes, blood cancer or another serious chronic condition
Extensive use of antibiotics or antifungal medicines
Risk depends on the person’s overall health, care environment and medical history. Therefore, one risk factor does not confirm infection. A healthcare professional must evaluate the complete situation.
What Are the Symptoms?
Candida auris symptoms vary according to the infected area. Fever and chills may occur, especially when the fungus enters the bloodstream.
However, these symptoms also occur with many common infections and cannot confirm C. auris.
A wound infection may cause pain, swelling, warmth, redness, or drainage. An ear infection may cause discomfort or discharge. Meanwhile, an invasive infection may lead to low blood pressure, a rapid heart rate, confusion, breathing problems, or severe weakness.
Some colonized patients have no symptoms. Therefore, symptoms alone cannot confirm the fungus. A laboratory must test blood, urine, wound material, or another sample to make a diagnosis.
Infection Risk & Primary Care
Not Sure Whether Your Symptoms Need Medical Attention?
A primary care provider can review your symptoms, recent healthcare exposure and medical history, then guide you toward the appropriate testing or level of care.
Seek emergency care for trouble breathing, confusion, fainting or severe weakness.
Why Is This Fungus Difficult to Treat?
The phrase drug-resistant superbug refers to the organism’s ability to survive medications that usually control infections. Although people often associate “superbug” with bacteria, the media also use the term for this drug-resistant fungal infection.
Doctors commonly start treatment with a group of antifungal medicines called echinocandins. Nevertheless, some strains resist one or more antifungal classes.
Rare strains may resist all three major classes, which can significantly limit treatment choices.
Treatment depends on the infection site, test results, and the patient’s condition. For this reason, hospital teams and infectious-disease specialists usually manage invasive cases. Patients should never take leftover or nonprescribed antifungal medicine.
Candida Auris Prevention
Effective Candida auris prevention requires strong infection-control practices. Healthcare facilities may screen high-risk patients, use contact precautions, and place affected patients in private rooms when possible. Staff members also clean rooms and shared equipment with disinfectants that work against C. auris.
Patients and visitors can take several practical steps:
Clean your hands before and after visiting a patient.
Follow facility instructions about gowns and gloves.
Avoid touching catheters, tubes, or medical equipment.
Remind healthcare workers about hand hygiene when appropriate.
Tell every care facility about a previous C. auris diagnosis.
Keep wounds clean and follow discharge instructions carefully.
Household members generally face a low risk. Still, everyone should wash their hands before and after helping with wounds or medical devices at home. The CDC’s C. auris guidance offers additional prevention information.
How Can Primary Care Help?
Primary care can provide an appropriate starting point for nonemergency concerns. A provider can review recent hospital or nursing-home exposure, assess symptoms, and identify personal risk factors.
Furthermore, primary care can help manage conditions such as diabetes that may increase vulnerability to infection. Your provider can also coordinate testing, hospital evaluation, and an infectious-disease referral when necessary.
However, a primary care office does not independently manage a severe invasive infection. Hospital and specialist teams provide advanced testing, isolation precautions, and antifungal treatment.
When Should You Seek Medical Care?
Contact a healthcare provider if you develop persistent fever or chills after a hospital or long-term care stay. You should also call if a wound develops increasing pain, redness, warmth, swelling, or drainage.
Tell the clinic before your visit if another facility previously identified C. auris colonization or infection. This information helps the care team plan suitable precautions.
Seek emergency care for trouble breathing, confusion, fainting, severe weakness, or signs of very low blood pressure. These symptoms may indicate sepsis or another medical emergency.
Stay Informed Without Panicking
Candida auris deserves attention because it can spread in healthcare facilities and resist treatment. Nevertheless, the general public faces a low risk. Awareness, hand hygiene, and open communication about previous healthcare exposure can help protect vulnerable patients.
Primary Care Guidance
Have Health Concerns After a Recent Hospital Stay?
Schedule a visit to discuss unexplained symptoms, recent healthcare exposure and personal risk factors. Our primary care team can evaluate your concerns and guide you toward the appropriate next step.
Passion Health Advanced Primary Care Locations
Frequently Asked Questions
1. Is Candida auris contagious?
Yes, it can spread through contact with colonized people, contaminated equipment, or healthcare surfaces. However, most transmission occurs inside healthcare facilities.
2. Can healthy people develop an infection?
Healthy people without major risk factors generally face a low risk. Serious cases mostly affect patients who already have complex illnesses or invasive medical devices.
3. Is Candida auris always deadly?
No. It does not cause death in every person. However, an invasive infection can become life-threatening, especially when a patient already has a serious illness.
4. Is it a common yeast infection?
No. C. auris differs from the Candida species that commonly cause vaginal infections, oral thrush, and routine skin infections.
5. Can primary care diagnose it?
A provider can assess your symptoms and exposure history. However, specialized laboratory testing may be needed to confirm the fungus.
